SNY Sanofi American Depositary Shares (Each representing one-half of one ordinary share) Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Source
11:08
Oct 01
Oct 01
Bloomberg Markets
Sanofi pipeline boosted by Regeneron deal.
Sanofi is expanding its Regeneron partnership into new antibody drugs focused on the immune system, a positive for its future pipeline as the patent on its primary drug with Regeneron expires.
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Long
1ST
—
11:16
Jul 24
Jul 24
Avoid SNY: author says Sanofi has lost amlitelimab, riliprubart.
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Avoid
—
11:07
Jul 24
Jul 24
Avoid SNY: author says Sanofi discontinued amlitelimab over safety concerns after previously.
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Avoid
—
About SNY Investor Commentary
Across the available history and selected sources, Buzzberg tracks SNY (Sanofi American Depositary Shares (Each representing one-half of one ordinary share)) across 10 sources: 2 bullish vs 1 bearish calls from 17 authors. Historical directional balance: 2% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 49 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish, 2 other directions. Latest voices: Alex, A May MD.